Jushi Holdings Inc. (JUSHF) Earnings Call Transcripts

29 earnings calls from May 2020 to July 28, 2026

OTCPK US Health Care Pharmaceuticals

Jushi Holdings Inc.'s Latest Earnings Call - Q4 FY2025

In the fourth quarter of fiscal year 2025, Jushi Holdings Inc. reported revenue of $68.3 million, reflecting a year-over-year growth of approximately 4%, while full-year revenue reached $262.9 million, up just over 2% from the previous year. The company reported a net loss of $15.6 million for the quarter, compared to a loss of $12.5 million in the prior year. Management highlighted a successful refinancing of $160 million, enhancing financial flexibility and positioning the company for growth, particularly with the anticipated transition to adult-use cannabis in Virginia in January 2027.

Reported metrics

MetricValueContext
Revenue $68.3 million (beat) vs $65.9 million in Q4 2024, +4% YoY
Gross Profit $28.6 million (beat) 41.9% of revenue vs 38.6% in Q4 2024
Adjusted EBITDA $13.9 million (beat) 20.4% margin vs $8 million, 12.2% in Q4 2024
Net Loss $15.6 million (miss) vs $12.5 million loss in Q4 2024
Full Year Revenue $262.9 million (inline) up just over 2% from 2024
Debt $193.1 million (neutral) excluding promissory notes and leases

Guidance from management

For 2026, Jushi expects maintenance CapEx to be approximately $4 million to $5 million, with growth CapEx projected at $5 million to $8 million, contingent on regulatory developments in Virginia.

What management said

1/3 -- we could do 1/3, 1/3, 1/3. We could propose whatever we would like to do. First payment would have to be made by December 1 of this year with expectation of sales starting on 1/1/27, and then we can space it out however we see fit and agree with the CCA on that.
— Trenton Woloveck, Q4 FY2025 earnings call

What analysts pressed on

Analysts expressed concerns regarding the sequential decline in gross margins and the competitive pricing pressures impacting profitability. There were also questions about the timing and scale of capital expenditures related to the anticipated adult-use market in Virginia and how it might affect future financial performance.

Main topics on the call

Read the full Jushi Holdings Inc. transcript (Q4 FY2025) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Jushi Holdings Inc.

Jushi Holdings Inc. (JUSHF) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on OTCPK and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 29 calls on record spanning May 7, 2020 to July 28, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 29 Jushi Holdings Inc. earnings call transcripts on record, spanning May 7, 2020 to July 28, 2026. Based on this history, Jushi Holdings Inc. reports quarterly. The most recent call on file is dated July 28, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
JUSHF
Exchange
OTCPK
Country
US
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
29
First call
May 7, 2020
Most recent
July 28, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Jul 28, 2026 Read transcript
Q1 FY2026 May 12, 2026 Read transcript
Q4 FY2025 Mar 31, 2026 Read transcript
Q3 FY2025 Nov 4, 2025 Read transcript
Q2 FY2025 Aug 5, 2025 Read transcript
Q4 FY2024 Mar 6, 2025 Read transcript
Q3 FY2024 Nov 7, 2024 Read transcript
Q2 FY2024 Aug 7, 2024 Read transcript
Q1 FY2024 May 9, 2024 Read transcript
Q4 FY2023 Mar 13, 2024 Read transcript
Q3 FY2023 Nov 14, 2023 Read transcript
Q2 FY2023 Aug 11, 2023 Read transcript
Q1 FY2023 May 12, 2023 Read transcript
Q4 FY2022 Mar 31, 2023 Read transcript
Q3 FY2022 Nov 14, 2022 Read transcript
Q2 FY2022 Aug 29, 2022 Read transcript
Special Calls Jul 14, 2022 Read transcript
Q1 FY2022 May 25, 2022 Read transcript
Q4 FY2021 Mar 24, 2022 Read transcript
Special Calls Feb 15, 2022 Read transcript
Q3 FY2021 Nov 17, 2021 Read transcript
Q2 FY2021 Aug 25, 2021 Read transcript
Q1 FY2021 Jun 9, 2021 Read transcript
Q3 FY2020 Nov 24, 2020 Read transcript
Analyst/Investor Day Oct 1, 2020 Read transcript
Q2 FY2020 Aug 27, 2020 Read transcript
Company Conference Presentations Aug 13, 2020 Read transcript
Q1 FY2020 Jul 7, 2020 Read transcript
Q4 FY2019 May 7, 2020 Read transcript